Il trattamento farmacologico della sindrome fibromialgica

Translated title of the contribution: Fibromyalgia syndrome: The pharmacological treatment options

Piercarlo Sarzi-Puttini, R. Torta, F. Marinangeli, G. Biasi, M. Spath, D. Buskila, R. H. Gracely, M. A. Giamberardino, L. Bazzichi, M. Cazzola, M. Di Franco, S. Stisi, F. Salaffi, R. Casale, G. Leardini, R. Gorla, A. Marsico, R. Carignola, L. Altomonte, F. CeccherelliG. Cassisi, G. Arioli, A. Alciati, F. Atzeni

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of fibromyalgia (FM) symptoms. Currently, it is not possible to draw definite conclusions concerning the best pharmacological approach to managing FM because results of randomized clinical trials present methodological limitations and therapeutic programs are too heterogeneous for adequate comparison. However, a variety of pharmacological treatments including antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDS), opioids, sedatives, muscle relaxants and antiepileptics have been used to treat FM with varying results. In this review, we will evaluate those pharmacological therapies that have produced the most significant clinical results in treating FM patients. The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date.

Original languageItalian
Pages (from-to)50-58
Number of pages9
JournalReumatismo
Volume60
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2007

Fingerprint

Fibromyalgia
Pharmacology
Therapeutics
Hypnotics and Sedatives
Pharmaceutical Preparations
Anticonvulsants
Opioid Analgesics
Antidepressive Agents
Anti-Inflammatory Agents
Randomized Controlled Trials
Muscles

ASJC Scopus subject areas

  • Rheumatology

Cite this

Sarzi-Puttini, P., Torta, R., Marinangeli, F., Biasi, G., Spath, M., Buskila, D., ... Atzeni, F. (2007). Il trattamento farmacologico della sindrome fibromialgica. Reumatismo, 60(SUPPL. 1), 50-58. https://doi.org/10.4081/reumatismo.2008.1s.50

Il trattamento farmacologico della sindrome fibromialgica. / Sarzi-Puttini, Piercarlo; Torta, R.; Marinangeli, F.; Biasi, G.; Spath, M.; Buskila, D.; Gracely, R. H.; Giamberardino, M. A.; Bazzichi, L.; Cazzola, M.; Di Franco, M.; Stisi, S.; Salaffi, F.; Casale, R.; Leardini, G.; Gorla, R.; Marsico, A.; Carignola, R.; Altomonte, L.; Ceccherelli, F.; Cassisi, G.; Arioli, G.; Alciati, A.; Atzeni, F.

In: Reumatismo, Vol. 60, No. SUPPL. 1, 2007, p. 50-58.

Research output: Contribution to journalArticle

Sarzi-Puttini, P, Torta, R, Marinangeli, F, Biasi, G, Spath, M, Buskila, D, Gracely, RH, Giamberardino, MA, Bazzichi, L, Cazzola, M, Di Franco, M, Stisi, S, Salaffi, F, Casale, R, Leardini, G, Gorla, R, Marsico, A, Carignola, R, Altomonte, L, Ceccherelli, F, Cassisi, G, Arioli, G, Alciati, A & Atzeni, F 2007, 'Il trattamento farmacologico della sindrome fibromialgica', Reumatismo, vol. 60, no. SUPPL. 1, pp. 50-58. https://doi.org/10.4081/reumatismo.2008.1s.50
Sarzi-Puttini P, Torta R, Marinangeli F, Biasi G, Spath M, Buskila D et al. Il trattamento farmacologico della sindrome fibromialgica. Reumatismo. 2007;60(SUPPL. 1):50-58. https://doi.org/10.4081/reumatismo.2008.1s.50
Sarzi-Puttini, Piercarlo ; Torta, R. ; Marinangeli, F. ; Biasi, G. ; Spath, M. ; Buskila, D. ; Gracely, R. H. ; Giamberardino, M. A. ; Bazzichi, L. ; Cazzola, M. ; Di Franco, M. ; Stisi, S. ; Salaffi, F. ; Casale, R. ; Leardini, G. ; Gorla, R. ; Marsico, A. ; Carignola, R. ; Altomonte, L. ; Ceccherelli, F. ; Cassisi, G. ; Arioli, G. ; Alciati, A. ; Atzeni, F. / Il trattamento farmacologico della sindrome fibromialgica. In: Reumatismo. 2007 ; Vol. 60, No. SUPPL. 1. pp. 50-58.
@article{8868a2e597d34bad9cf6ea569beff93f,
title = "Il trattamento farmacologico della sindrome fibromialgica",
abstract = "Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of fibromyalgia (FM) symptoms. Currently, it is not possible to draw definite conclusions concerning the best pharmacological approach to managing FM because results of randomized clinical trials present methodological limitations and therapeutic programs are too heterogeneous for adequate comparison. However, a variety of pharmacological treatments including antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDS), opioids, sedatives, muscle relaxants and antiepileptics have been used to treat FM with varying results. In this review, we will evaluate those pharmacological therapies that have produced the most significant clinical results in treating FM patients. The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date.",
keywords = "Antiepileptics, Non-pharmacologic approach, Nonsteroidal anti-inflammatory drugs, Opioids, Pharmacologic approach",
author = "Piercarlo Sarzi-Puttini and R. Torta and F. Marinangeli and G. Biasi and M. Spath and D. Buskila and Gracely, {R. H.} and Giamberardino, {M. A.} and L. Bazzichi and M. Cazzola and {Di Franco}, M. and S. Stisi and F. Salaffi and R. Casale and G. Leardini and R. Gorla and A. Marsico and R. Carignola and L. Altomonte and F. Ceccherelli and G. Cassisi and G. Arioli and A. Alciati and F. Atzeni",
year = "2007",
doi = "10.4081/reumatismo.2008.1s.50",
language = "Italian",
volume = "60",
pages = "50--58",
journal = "Reumatismo",
issn = "0048-7449",
publisher = "PAGEPRESS PUBL",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Il trattamento farmacologico della sindrome fibromialgica

AU - Sarzi-Puttini, Piercarlo

AU - Torta, R.

AU - Marinangeli, F.

AU - Biasi, G.

AU - Spath, M.

AU - Buskila, D.

AU - Gracely, R. H.

AU - Giamberardino, M. A.

AU - Bazzichi, L.

AU - Cazzola, M.

AU - Di Franco, M.

AU - Stisi, S.

AU - Salaffi, F.

AU - Casale, R.

AU - Leardini, G.

AU - Gorla, R.

AU - Marsico, A.

AU - Carignola, R.

AU - Altomonte, L.

AU - Ceccherelli, F.

AU - Cassisi, G.

AU - Arioli, G.

AU - Alciati, A.

AU - Atzeni, F.

PY - 2007

Y1 - 2007

N2 - Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of fibromyalgia (FM) symptoms. Currently, it is not possible to draw definite conclusions concerning the best pharmacological approach to managing FM because results of randomized clinical trials present methodological limitations and therapeutic programs are too heterogeneous for adequate comparison. However, a variety of pharmacological treatments including antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDS), opioids, sedatives, muscle relaxants and antiepileptics have been used to treat FM with varying results. In this review, we will evaluate those pharmacological therapies that have produced the most significant clinical results in treating FM patients. The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date.

AB - Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of fibromyalgia (FM) symptoms. Currently, it is not possible to draw definite conclusions concerning the best pharmacological approach to managing FM because results of randomized clinical trials present methodological limitations and therapeutic programs are too heterogeneous for adequate comparison. However, a variety of pharmacological treatments including antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDS), opioids, sedatives, muscle relaxants and antiepileptics have been used to treat FM with varying results. In this review, we will evaluate those pharmacological therapies that have produced the most significant clinical results in treating FM patients. The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date.

KW - Antiepileptics

KW - Non-pharmacologic approach

KW - Nonsteroidal anti-inflammatory drugs

KW - Opioids

KW - Pharmacologic approach

UR - http://www.scopus.com/inward/record.url?scp=69249221648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249221648&partnerID=8YFLogxK

U2 - 10.4081/reumatismo.2008.1s.50

DO - 10.4081/reumatismo.2008.1s.50

M3 - Articolo

C2 - 18852908

AN - SCOPUS:69249221648

VL - 60

SP - 50

EP - 58

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - SUPPL. 1

ER -